Author name: Pankhuri Agarwal

SpicyIP Events: International IP Skills Summit 2016 in Bangalore

/ By / Event

We are happy to announce the International Intellectual Property Skills Summit 2016 (IIPSS), to be held on November 11 & 12, 2016 in Bangalore, the Silicon Valley of India, and home to around 500+ Global R&D centers. IIPSS will be a unique opportunity of its kind to exchange ideas, learn best practices, debate on recent intellectual property issues and their impact on the industry, build industry awareness and network with various stakeholders. IIPSS is an annual gathering of Chief IP […]

SpicyIP Events: International IP Skills Summit 2016 in Bangalore Read More »

“Made in India” Innovation Policy

/ By / Innovation, Patent

We are happy to bring to our readers a guest post by two esteemed US law professors,  Prof. Colleen V. Chien and Prof. Jorge L. Contreras. In this post they emphasize upon the need for data-driven IP policy making in India. We had blogged on this theme earlier here. “Made in India” Innovation Policy Prof. Colleen V. Chien and Prof. Jorge L. Contreras A few weeks ago we were honored to participate in Jindal Global Law School’s Conference on “Innovation for Shared Prosperity”.

“Made in India” Innovation Policy Read More »

SpicyIP Events: IP Law Asia Summit 2016 in Kuala Lumpur, Malaysia

/ By / Event

SpicyIP is pleased to announce the IP Law Asia Summit 2016 that will be taking place on October 24 & 25, 2016 at The Westin Kuala Lumpur, Kuala Lumpur, Malaysia. IP Law Asia Summit is the premium forum bringing together leading in-house IP counsels with specialist international law firms, IP attorneys and legal services providers in an intimate environment for a focused discussion of the key new drivers shaping the IP profession. Taking place at The Westin Kuala Lumpur, Malaysia on 24

SpicyIP Events: IP Law Asia Summit 2016 in Kuala Lumpur, Malaysia Read More »

Merck’s (Atomic Energy) Patent – Fizzles!!

/ By / Patent

We are happy to bring to you another guest post by Sribindu Chivukula. Sribindu graduated in Chemistry from State University of New York, Buffalo in the year 2012. She is a registered Indian patent agent and is presently associated with a leading law firm based out of Delhi. All views expressed in the post are her personal views.       Merck’s (Atomic Energy) Patent – Fizzles!! Sribindu Chivukula This post discusses the case where a national phase patent application (2996/KOLNP/2009) filed by Merck

Merck’s (Atomic Energy) Patent – Fizzles!! Read More »

SpicyIP Events: 5th Annual Global IP Conclave & Awards 2016, Mumbai

/ By / Event

SpicyIP is happy to announce the 5th Annual Global Intellectual Property (IP) Conclave & Awards 2016 (GIPCA) that will take place on November 10 & 11, 2016 in Mumbai. GIPCA is an industry leading event dedicated to bringing together IP owners, experts, lawyers and investors to address key challenges and operational issues faced by companies and IP professionals today. As an industry networking platform, the Conclave provides meaningful and valuable insights in IP generation as well as managing, protecting, enforcing

SpicyIP Events: 5th Annual Global IP Conclave & Awards 2016, Mumbai Read More »

On Bt Cotton, FRAND Licensing and Recent Governmental Initiatives: Putting Things in Context – II

/ By / Plant Variety Protection

In Part I of this guest post, Dr. Mrinalini Kochupillai recommended against immediate incorporation of Bt technology into all cotton seeds (typical or hybrid) in India. In Part II of the post below, she discusses the reasons for this recommendation.     On Bt Cotton, FRAND Licensing and Recent Governmental Initiatives: Putting Things in Context – II Dr. Mrinalini Kochupillai Promoting Indigenous Private Sector R&D It may well be pure conjecture that the government’s efforts to reduce the price of Bt technology under its

On Bt Cotton, FRAND Licensing and Recent Governmental Initiatives: Putting Things in Context – II Read More »

On Bt Cotton, FRAND Licensing and Recent Governmental Initiatives: Putting Things in Context – I

/ By / Plant Variety Protection

We are happy to bring to you a two part guest post by one of our former bloggers, Dr. Mrinalini Kochupillai. Mrinalini is a senior research fellow at the Max Planck Institute for Innovation and Competition, Munich and a Program Director and faculty member at the Munich Intellectual Property Law Center (MIPLC). She has been associated with the MIPLC and the Max Planck Institute since 2008, first as an independent MIPLC research fellow (2008-2009) and then as a doctoral fellow with the International

On Bt Cotton, FRAND Licensing and Recent Governmental Initiatives: Putting Things in Context – I Read More »

Puzzling Patents

/ By / Patent

We are happy to bring to you an interesting guest post by Jasneet Kaur. Jasneet is an independent legal practitioner with extensive experience in trade mark law, having worked with the IPR divisions of two leading law firms in Delhi. This post is in response to an e-mail sent by Prof. Basheer to our subscribers last week, wherein he kickstarted a new column on weird/interesting patents with a 1965 patent for an apparatus for facilitating the birth of a child by centrifugal force.

Puzzling Patents Read More »

The End of the Dishoom Saga: Better “Blocking” Message and Neutral Ombudsman

/ By / Copyright

By the looks of it, the Dishoom John Doe saga appears to have come to a close. Well almost! In an order passed three days ago, Justice Patel asked all ISPs to replace a faulty error message that caused much problem in public perception. He also pressed the need for a neutral ombudsman for verification of plaintiffs’ claims and resolution of blocking disputes; an idea proposed by Prof. Basheer and developed in a recent piece in the Wire. But first

The End of the Dishoom Saga: Better “Blocking” Message and Neutral Ombudsman Read More »

Cipla Withdraws Revocation Plea for Novartis’ Onbrez Patents, Informs DIPP in an RTI Reply

/ By / Patent

Many of our readers may have been wondering about the status of the application that Cipla made to DIPP in October 2014 for revocation of Novartis’ patents for the drug Onbrez. DIPP’s recent reply to an RTI application (RTI) has put an end to this wondering. Mr. Pradeep Kumar, who filed about 27 RTIs between October 2014 and June 2016 seeking the status of this application, was informed by the DIPP on June 13 that the application had been withdrawn

Cipla Withdraws Revocation Plea for Novartis’ Onbrez Patents, Informs DIPP in an RTI Reply Read More »

Scroll to Top